A career highlight for Dr. Levin focuses on clinical recommendations derived from an interventional clinical study investigating the treatment of optic neuropathy with corticosteroids, surgery or without any treatment. He discovered that steroid and surgery did not provide a clear benefit to patient outcome and that the decision to treat or not treat should be reasonably decided on an individual patient basis. Dr. Levin proposed in a special article to JAMA Ophthalmology that neuroprotection of the retinal ganglion cells or optic nerve fibers should be explored as an adjunctive therapy to lowering the intraocular pressure via topical drops or surgical intervention as a treatment for glaucoma. This insight was well ahead of his time and is an active field of research in ophthalmology today.
The treatment of traumatic optic neuropathy: The International Optic Nerve Trauma Study
Is neuroprotection a viable therapy for glaucoma?
Fellowship: Neuro-ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
Residency: Massachusetts Eye and Ear Infirmary, Boston, MA
Internship: Mt. Auburn Hospital, Cambridge, MA
Medical School: Harvard Medical School and Harvard-MIT Program in Health Sciences and Technology, Cambridge, MA
Additional Studies: PhD, Department of Neurobiology, Harvard University, Cambridge, MA